Advertisement

Topics

Agile Therapeutics Provides Regulatory Update and Reiterates Cash Guidance

12:26 EST 11 Jan 2019 | Investing News Network

Agile Therapeutics (Nasdaq:AGRX), a women’s healthcare company, announced that on January 9, 2019 it received final meeting minutes from its December 11, 2018 meeting with the U.S. Food and Drug Administration’s Division of Bone, Reproductive, and Urologic Products. As quoted in the press release: In its meeting with DBRUP, the Company discussed the specific design … Continued

The post Agile Therapeutics Provides Regulatory Update and Reiterates Cash Guidance appeared first on Investing News Network.

Original Article: Agile Therapeutics Provides Regulatory Update and Reiterates Cash Guidance

NEXT ARTICLE

More From BioPortfolio on "Agile Therapeutics Provides Regulatory Update and Reiterates Cash Guidance"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...